際際滷

際際滷Share a Scribd company logo
Optic Nerve Sheath
 Diameter ( ONSD )
    in Increased
intracnial Pressures
        ( ICP )
 A new tool in the Ultrasound Era
Causes of ICP

Obstruction CSF flow and/or    Mass effect:

 Hydrocephalus
       absorption :
                                   Malignancy

 Extensive meningeal
 disease (e.g., infectious,
                                   CVA with edema
                                   Cerebral contusions
  carcinomatous,                   subdural or epidural hematoma


  
  granulomatous )                    abscess
    Superior sagittal sinus
  (decreased absorption)        Diffuse Encephalopathies:
                                   Acute liver failure
Increased CSF production :        Hypertensive Encephalopthy
  Meningitis                      High Altitude cerebral edema
 Subarachnoid hemorrhage,         Uremic Encephalopathy
                                   PseudotumorCerebri
Why look at ONSD?

 How do we currently assess EICP :
   Non-specific signs and symptoms
   Imaging CT scan/MRI
   Pulsatliity index
   Invasive monitoring
   Papilledema
CT and ICP

 Moving patients
 Repeat for head CT  one third of trauma
  need repeat head CT looking for ICP .
  Radiographic delay?
 Initial head CTs of 100 head injured trauma
  patients evaluated by group of 12
  radiologists :
   Sensitivity 83% , Specifity 78%
Invasive ICP measurments

 Gold standard External Ventricular Device

 Comlipcated/ invasive procedure

 Risks  Infection, parenchymal injury
 , bleeding
 Bleeding diasthesis
Oprtic1.nerve sheath
Gold standard for ICP
External Ventricular Device ( EVD )
Papilledema

 Operator dependant

 Delayed manifestation: - 24 hrs

 May persist for several days to weeks after treatment
Papilledema ?



  Both are Normal
Oprtic1.nerve sheath
Outline

 Basic anatomy of the Optic nerve and its sheath

 How to measure ONSD?

 Rationale and evidence for using the ONSD for Increased
  intracerebral pressure ( ICP )

 Uses and rationale in different clinical settings :
   ESRD , ESLD ,HTN crises and altitude sickness
ONSD basic anatomy

 Optic Nerve:
   White matter tract direct extension of the CNS surrounded
    by CSF
   Sensitive to changes to CSF flow and intracerebral pressures
    ( ICP )
Intra-orbital CSF




                    h




                    Intracranial CSF
Optic Nerve
ONSD history

 British opthalmologistHayreh

 The mechanism of papiledema from increased ICP

 Placed inflatable balloons in the brain of monkeys
Oprtic1.nerve sheath
Oprtic1.nerve sheath
Oprtic1.nerve sheath
Rapid response ONSD

 Hansen et al :
   Infused NS into CSF
   Changes in ONSD occurred within minutes
   Mean change of 1.97mm or around 83% increase
   Relieving pressure  rapid decrease in size
   Exception was with prolonged exposure to very high
      pressures showed a delay in regression

          Changes in ONSD mimics changes in ICP
  Acta Ophthalmol. 2011 Sep;89(6):e528-32.
How do we measure the ONSD?

 3-7.5Mhz Probe

 Supine position at around 20 degrees phlebotactic axis

 Perpendicular axis at 3mm behind ON entry point

 2 reading on each eye

 Probe applied directly over the eyelid

 Cutoff 5mm or 5.7mm
3mm


ONSD
3mm


ONSD
Lens




                     Vitreous




 A-A 0.3cm


B-B 0.62 cm
ONSD False Positive

 Emerg Med J 2007;24:251254. doi:
  10.1136/emj.2006.040931


                                                            Volume status




           Emerg Med J 2007;24:251254. doi: 10.1136/emj.2006.040931 Abdullah
           SadikGirisgin, ErdalKalkan, SedatKocak, BasarCander, MehmetGul, Mustafa
           Semiz
Reproducible results

 54 patients:
   28 confirmed EICP via CT scan
   26 no evidence of EICP
Oprtic1.nerve sheath
ONSD evidence based approach

 Most studies  Trauma or neurosurgical patients

 3 major studies on ONSD ( briefly )
ONSD evidence

 Prospective study on 26 ED patients

 ONSD cutoff > 0.5 cm


                                        All had CT scans




Emer Med J published online August 15, 2010 ,Robert Major, Simon Girling and Adrian Boyleg
永永閣100%
               NPV95%

Sens 86%
Sepcificity 99% for
EICP
                          ONSD cutoff >5mm
ONSD evidence

 Small sample size

 Non-trauma  GSC: 8

 Compared to CT scan
Invasive and non-invasive
                  comparison

                              76 patients

                                    Pulsatility index

   26 Control                   18                    32
                              Moderate              Severe

                                                  Invasive ICP
Moderate  Marshall score I and GSC > 8            monitoring
Severe  Marshall score >I and GCS < 8
76 patients



Brain CT injury scale   No CT done   Normal CT         Abnormal CT
                                                 18%                 82%


                         ONSD cutoff 5.7mm
Non-invasive   Invasive Monitoring
monitoring
ROC :0.93
      Sens : 74%
      Spec: 99%


ONSD cutoff >
5.7mm




TheodorosSoldtos, Optic nerve sonography in the
diagnostic
Evaluation of adult brain injury, Critical care 2008;12
R 67
Prospective Blind observational
              trial
          31 ICU patients with severe TBI
                   GSC<8


16 EICP                                                                15 Normal ICP

            All patients underwent invasive
                     ICP monitoring

                     Intensive Care Med (2007) 33:17041711, T. Geeraerts () 揃 Y. Launey 揃 L. Martin 揃J. Pottecher
                     揃 B. Vigu辿 揃 J. Duranteau 揃D. Benhamou
5.7 mm
ROC: 0.96
Sens: 91%
Spec: 94%




            Thomas Geerats M.D, Ultrasonography of Optic
            nerve
            Sheath may be useful in detecting raised ICP
            After head trauma. Intensive care Medicine
            2007, 33:1704-1711
ONSD evidence conclusion

 Cutoff> 5.7mm for EICP 
   Sensitivity of around 93%
   Specificity: 96%

 5-5.7mm  Sensitivity is maintained however Specificity
  declines to 83%

 Screening tool

 Surrogate marker for EICP
ICP causes
Obstruction CSF flow and/or               Diffuse Encephalopathies:
absorption :                                 ESLD
                                             ESRD
   Hydrocephalus                            Hypertensive Encephalopthy
                                             High Altitude cerebral edema
   Extensive meningeal disease granulo
   (e.g., infectious, carcinomatous,
   matous )                               Mass effect:
   Superior sagittal sinus (decreased       Malignancy

   absorption)                               CVA with edema

Increased CSF production :                   Cerebral contusions

   Meningitis                               Subdural or epidural hematoma

   Subarachnoid hemorrhage,                 Abscess
Study

 Prospective observational/descriptive analysis

 Medicine patient admitted to general medicine floor , MICU
  ESLD / ESRD / HTN crisis
 No head / ocular trauma

 No other cause for EICP

 Comparing ONSD diameter of non-encephalopathy v/s
  encephalopathy pre-treatment /24hrs post-treatment
 Convenience sample
Hypothesis

 Absolute value of ONSD would be high among the
  encephalopathic group and would normalize after
  treatment

 Statistically significant change in ONSD pre and post
  treatment
Definitions

 EICP: - > 20 mmHg, If invasive monitoring available .
   Radiographic evidence of raised ICP as determined by
     CT

 ONSD : cut-off of 5.7 mm to define enlarged ONSD ,

 ESLD and Uremia straightforward

 HTN encephalopathy ? Unclear and vague definition.
Method

 7-12 MHz while patient is at 20 degree angle

 2 measurements from each eye ( for a total of 4 per patient
  )

 Measurements will be taken both prior and within 24hrs
  after treatment
ESLD and ICP

 Fulminant hepatic failure  80% EICP

 Ammonia and Manganese astrocyte edema

 Chronic ESLD  EICP only in stage IV hepatic
  encephalopathy
N=24

                                                 No
          Encephalopathy                    Encephalopathy



             N=10                                    N=14



Stage I           Stage II          Stage III       Stage IV
 N=2                N=5               N=3             N=0
Pretreament ESLD
10                                          Stage I
     ONSD in mm
9                                           Stage II
8                                           Stage III
 7
6
                                            5.7mm
 5
4
 3
2
 1
       N= 14                 N=10
0
                        Encephalopathy
 No Encephalopathy    With Encephalopathy
Post-treament ESLD
10
                                                       Stage I
     ONSD in mm
9                                                      Stage II
8                                                      Stage III
 7
                               Relative decrease 57%
6
                                                       5.7mm
 5
4
 3
2
 1
       N= 14                  N= 10
0
                         Encephalopathy
 No Encephalopathy     With Encephalopathy
Summary ESLD
              Pretreatment                          Post-treatment
10       ONSD in mm                    10                         Stage I
 9                                      9
                                                                  Stage II
 8                                      8
 7                                      7
                                                                  Stage III
 6                                      6                                  5.7mm
 5                                      5
 4                                      4
 3                                      3
 2                                      2
 1                                      1
 0                         N= 8         0                     N= 8
      N= 14                                 N= 14
No Encephalopathy          With             No                 With
                      Encephalopathy   Encephalopathy     Encephalopathy
ESRD and ICP

 Dialysis Dysequilibrium Syndrome

 Very high BUN > 110
Pretreatment ESRD

           Pretreatment                        Post-treatment
10
     ONSD in mm
9
8
 7
                                       46 %decrease        63% decrease
6
5
4
 3
2
        N= 13            N= 4
 1
          No              With               No               With
0
     Encephalopathy   Encephalopathy    Encephalopathy   Encephalopathy
           yes                                     No          1/9/02
Data analysis

 Relative decrease in ONSD in both groups was significant
   NO encephalopathy: - 46%
   With Encephalopathy: - 63%

 Other etiologies for increase ONSD :
   Volume status
   HTN

 Utility in predicting DDS?
HTN crisis

 Most common manifestation are neurologic :
   44% with HTN emergency have neurologic manifestations
   16% HTN encephalopathy

 Clinically subtle

 Pathophysiology Breakthrough autoregulation

 CT head to r/o CVA helpful however in HTN
  encephalopathy not so much
Oprtic1.nerve sheath
Oprtic1.nerve sheath
HTN crisis

          Pretreatment                      Post-treatment
10
     ONSD in mm                                         Encephalopathic
9
       5.2mm             7.2mm
8
 7
                                    57% decrease         68% decrease
6
5
4
 3
2
       N= 11           N= 5
 1
     Uncontrolled   HTN emergency   Uncontrolled          HTN emergency
0
        HTN                            HTN
          yes                                      No         1/9/02
Data analysis

 Uncontrolled HTN had rather high ONSD subclinical
  EICP

 Relative size decrease :
   57% in Uncontrolled HTN
   68% HTN emergency
High altitude sickness

 No data yet

 14ers ONSD at base , peak , base

 Symptoms of Altitude sickness

 ONSD absolute value and change
Conclusion

 ONSD: Reliable surrogate marker for EICP

 Quick bedside evaluation that competes with CT scans

 Reproducible results easy to learn

 Large area of research

 Downfalls: - Etiology
Thank you

More Related Content

Oprtic1.nerve sheath

  • 1. Optic Nerve Sheath Diameter ( ONSD ) in Increased intracnial Pressures ( ICP ) A new tool in the Ultrasound Era
  • 2. Causes of ICP Obstruction CSF flow and/or Mass effect: Hydrocephalus absorption : Malignancy Extensive meningeal disease (e.g., infectious, CVA with edema Cerebral contusions carcinomatous, subdural or epidural hematoma granulomatous ) abscess Superior sagittal sinus (decreased absorption) Diffuse Encephalopathies: Acute liver failure Increased CSF production : Hypertensive Encephalopthy Meningitis High Altitude cerebral edema Subarachnoid hemorrhage, Uremic Encephalopathy PseudotumorCerebri
  • 3. Why look at ONSD? How do we currently assess EICP : Non-specific signs and symptoms Imaging CT scan/MRI Pulsatliity index Invasive monitoring Papilledema
  • 4. CT and ICP Moving patients Repeat for head CT one third of trauma need repeat head CT looking for ICP . Radiographic delay? Initial head CTs of 100 head injured trauma patients evaluated by group of 12 radiologists : Sensitivity 83% , Specifity 78%
  • 5. Invasive ICP measurments Gold standard External Ventricular Device Comlipcated/ invasive procedure Risks Infection, parenchymal injury , bleeding Bleeding diasthesis
  • 7. Gold standard for ICP External Ventricular Device ( EVD )
  • 8. Papilledema Operator dependant Delayed manifestation: - 24 hrs May persist for several days to weeks after treatment
  • 9. Papilledema ? Both are Normal
  • 11. Outline Basic anatomy of the Optic nerve and its sheath How to measure ONSD? Rationale and evidence for using the ONSD for Increased intracerebral pressure ( ICP ) Uses and rationale in different clinical settings : ESRD , ESLD ,HTN crises and altitude sickness
  • 12. ONSD basic anatomy Optic Nerve: White matter tract direct extension of the CNS surrounded by CSF Sensitive to changes to CSF flow and intracerebral pressures ( ICP )
  • 13. Intra-orbital CSF h Intracranial CSF
  • 15. ONSD history British opthalmologistHayreh The mechanism of papiledema from increased ICP Placed inflatable balloons in the brain of monkeys
  • 19. Rapid response ONSD Hansen et al : Infused NS into CSF Changes in ONSD occurred within minutes Mean change of 1.97mm or around 83% increase Relieving pressure rapid decrease in size Exception was with prolonged exposure to very high pressures showed a delay in regression Changes in ONSD mimics changes in ICP Acta Ophthalmol. 2011 Sep;89(6):e528-32.
  • 20. How do we measure the ONSD? 3-7.5Mhz Probe Supine position at around 20 degrees phlebotactic axis Perpendicular axis at 3mm behind ON entry point 2 reading on each eye Probe applied directly over the eyelid Cutoff 5mm or 5.7mm
  • 23. Lens Vitreous A-A 0.3cm B-B 0.62 cm
  • 24. ONSD False Positive Emerg Med J 2007;24:251254. doi: 10.1136/emj.2006.040931 Volume status Emerg Med J 2007;24:251254. doi: 10.1136/emj.2006.040931 Abdullah SadikGirisgin, ErdalKalkan, SedatKocak, BasarCander, MehmetGul, Mustafa Semiz
  • 25. Reproducible results 54 patients: 28 confirmed EICP via CT scan 26 no evidence of EICP
  • 27. ONSD evidence based approach Most studies Trauma or neurosurgical patients 3 major studies on ONSD ( briefly )
  • 28. ONSD evidence Prospective study on 26 ED patients ONSD cutoff > 0.5 cm All had CT scans Emer Med J published online August 15, 2010 ,Robert Major, Simon Girling and Adrian Boyleg
  • 29. 永永閣100% NPV95% Sens 86% Sepcificity 99% for EICP ONSD cutoff >5mm
  • 30. ONSD evidence Small sample size Non-trauma GSC: 8 Compared to CT scan
  • 31. Invasive and non-invasive comparison 76 patients Pulsatility index 26 Control 18 32 Moderate Severe Invasive ICP Moderate Marshall score I and GSC > 8 monitoring Severe Marshall score >I and GCS < 8
  • 32. 76 patients Brain CT injury scale No CT done Normal CT Abnormal CT 18% 82% ONSD cutoff 5.7mm
  • 33. Non-invasive Invasive Monitoring monitoring
  • 34. ROC :0.93 Sens : 74% Spec: 99% ONSD cutoff > 5.7mm TheodorosSoldtos, Optic nerve sonography in the diagnostic Evaluation of adult brain injury, Critical care 2008;12 R 67
  • 35. Prospective Blind observational trial 31 ICU patients with severe TBI GSC<8 16 EICP 15 Normal ICP All patients underwent invasive ICP monitoring Intensive Care Med (2007) 33:17041711, T. Geeraerts () 揃 Y. Launey 揃 L. Martin 揃J. Pottecher 揃 B. Vigu辿 揃 J. Duranteau 揃D. Benhamou
  • 37. ROC: 0.96 Sens: 91% Spec: 94% Thomas Geerats M.D, Ultrasonography of Optic nerve Sheath may be useful in detecting raised ICP After head trauma. Intensive care Medicine 2007, 33:1704-1711
  • 38. ONSD evidence conclusion Cutoff> 5.7mm for EICP Sensitivity of around 93% Specificity: 96% 5-5.7mm Sensitivity is maintained however Specificity declines to 83% Screening tool Surrogate marker for EICP
  • 39. ICP causes Obstruction CSF flow and/or Diffuse Encephalopathies: absorption : ESLD ESRD Hydrocephalus Hypertensive Encephalopthy High Altitude cerebral edema Extensive meningeal disease granulo (e.g., infectious, carcinomatous, matous ) Mass effect: Superior sagittal sinus (decreased Malignancy absorption) CVA with edema Increased CSF production : Cerebral contusions Meningitis Subdural or epidural hematoma Subarachnoid hemorrhage, Abscess
  • 40. Study Prospective observational/descriptive analysis Medicine patient admitted to general medicine floor , MICU ESLD / ESRD / HTN crisis No head / ocular trauma No other cause for EICP Comparing ONSD diameter of non-encephalopathy v/s encephalopathy pre-treatment /24hrs post-treatment Convenience sample
  • 41. Hypothesis Absolute value of ONSD would be high among the encephalopathic group and would normalize after treatment Statistically significant change in ONSD pre and post treatment
  • 42. Definitions EICP: - > 20 mmHg, If invasive monitoring available . Radiographic evidence of raised ICP as determined by CT ONSD : cut-off of 5.7 mm to define enlarged ONSD , ESLD and Uremia straightforward HTN encephalopathy ? Unclear and vague definition.
  • 43. Method 7-12 MHz while patient is at 20 degree angle 2 measurements from each eye ( for a total of 4 per patient ) Measurements will be taken both prior and within 24hrs after treatment
  • 44. ESLD and ICP Fulminant hepatic failure 80% EICP Ammonia and Manganese astrocyte edema Chronic ESLD EICP only in stage IV hepatic encephalopathy
  • 45. N=24 No Encephalopathy Encephalopathy N=10 N=14 Stage I Stage II Stage III Stage IV N=2 N=5 N=3 N=0
  • 46. Pretreament ESLD 10 Stage I ONSD in mm 9 Stage II 8 Stage III 7 6 5.7mm 5 4 3 2 1 N= 14 N=10 0 Encephalopathy No Encephalopathy With Encephalopathy
  • 47. Post-treament ESLD 10 Stage I ONSD in mm 9 Stage II 8 Stage III 7 Relative decrease 57% 6 5.7mm 5 4 3 2 1 N= 14 N= 10 0 Encephalopathy No Encephalopathy With Encephalopathy
  • 48. Summary ESLD Pretreatment Post-treatment 10 ONSD in mm 10 Stage I 9 9 Stage II 8 8 7 7 Stage III 6 6 5.7mm 5 5 4 4 3 3 2 2 1 1 0 N= 8 0 N= 8 N= 14 N= 14 No Encephalopathy With No With Encephalopathy Encephalopathy Encephalopathy
  • 49. ESRD and ICP Dialysis Dysequilibrium Syndrome Very high BUN > 110
  • 50. Pretreatment ESRD Pretreatment Post-treatment 10 ONSD in mm 9 8 7 46 %decrease 63% decrease 6 5 4 3 2 N= 13 N= 4 1 No With No With 0 Encephalopathy Encephalopathy Encephalopathy Encephalopathy yes No 1/9/02
  • 51. Data analysis Relative decrease in ONSD in both groups was significant NO encephalopathy: - 46% With Encephalopathy: - 63% Other etiologies for increase ONSD : Volume status HTN Utility in predicting DDS?
  • 52. HTN crisis Most common manifestation are neurologic : 44% with HTN emergency have neurologic manifestations 16% HTN encephalopathy Clinically subtle Pathophysiology Breakthrough autoregulation CT head to r/o CVA helpful however in HTN encephalopathy not so much
  • 55. HTN crisis Pretreatment Post-treatment 10 ONSD in mm Encephalopathic 9 5.2mm 7.2mm 8 7 57% decrease 68% decrease 6 5 4 3 2 N= 11 N= 5 1 Uncontrolled HTN emergency Uncontrolled HTN emergency 0 HTN HTN yes No 1/9/02
  • 56. Data analysis Uncontrolled HTN had rather high ONSD subclinical EICP Relative size decrease : 57% in Uncontrolled HTN 68% HTN emergency
  • 57. High altitude sickness No data yet 14ers ONSD at base , peak , base Symptoms of Altitude sickness ONSD absolute value and change
  • 58. Conclusion ONSD: Reliable surrogate marker for EICP Quick bedside evaluation that competes with CT scans Reproducible results easy to learn Large area of research Downfalls: - Etiology

Editor's Notes

  1. Increased popularity